Articles dans des revues avec comité de lecture (43)
  1. 13. Noval Rivas, M., Hazzan, M., Weatherly, K., Gaudray, F., Salmon, I., & Braun, M. Y. (2010). NK cell regulation of CD4 T cell-mediated graft-versus-host disease. The Journal of immunology, 184(12), 6790-6798. doi:10.4049/jimmunol.0902598
  2. 14. Noval Rivas, M., Weatherly, K., Hazzan, M., Vokaer, B., Dremier, S., Gaudray, F., Goldman, M., Salmon, I., & Braun, M. Y. (2009). Reviving function in CD4+ T cells adapted to persistent systemic antigen. The Journal of immunology, 183(7), 4284-4291. doi:10.4049/jimmunol.0901408
  3. 15. Kapessidou, P., Poulin, L., Dumoutier, L., Goldman, M., Renauld, J.-C., & Braun, M. Y. (2008). Interleukin-22 deficiency accelerates the rejection of full major histocompatibility complex-disparate heart allografts. Transplantation proceedings, 40(5), 1593-1597. doi:10.1016/j.transproceed.2008.03.151
  4. 16. Feunou, P., Vanwetswinkel, S., Gaudray, F., Goldman, M., Matthys, P., & Braun, M. Y. (2007). Foxp3+CD25+ T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolism that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B. The Journal of immunology, 179(2), 910-917.
  5. 17. Kapessidou, P., Habran, C., Buonocore, S., Flamand, V., Barvais, L., Goldman, M., & Braun, M. Y. (2006). The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells. Transplantation, 81(5), 726-735. doi:10.1097/01.tp.0000184444.93108.d1
  6. 18. Poulin, L. F., Habran, C., Stordeur, P., Goldman, M., McKenzie, A., Van Snick, J., Renauld, J.-C., & Braun, M. Y. (2005). Interleukin-9 stimulates the production of interleukin-5 in CD4+ T cells. European cytokine network, 16(3), 233-239.
  7. 19. Benghiat, F., Graca, L., Braun, M. Y., Detienne, S., Moore, F., Buonocore, S., Flamand, V., Waldmann, H., Goldman, M., & Le Moine, A. (2005). Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression. Transplantation, 79(6), 648-654. doi:10.1097/01.TP.0000155179.61445.78
  8. 20. Kapessidou, P., & Braun, M. Y. (2004). Recipient-derived endothelial cells in the rejection of cardiac allograft mediated by indirect-pathway T cells. Transplantation, 78(1), 515.
  9. 21. Feunou, P., Poulin, L., Habran, C., Le Moine, A., Goldman, M., & Braun, M. Y. (2003). CD4+CD25+ and CD4+CD25- T cells act respectively as inducer and effector T suppressor cells in superantigen-induced tolerance. The Journal of immunology, 171(7), 3475-3484.
  10. 22. Poulin, L., Richard, M., Le Moine, A., Kiss, R., McKenzie, A., Goldman, M., Renauld, J.-C., Van Snick, J., & Braun, M. Y. (2003). Interleukin-9 promotes eosinophilic rejection of mouse heart allografts. Transplantation, 76(3), 572-577. doi:10.1097/01.TP.0000071201.32424.D2
  11. 23. Buonocore, S., Flamand, V., Goldman, M., & Braun, M. Y. (2003). Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. Transplantation, 75(3), 407-413. doi:10.1097/01.TP.0000044172.19087.22
  12. 24. Buonocore, S., Paulart, F., Le Moine, A., Braun, M. Y., Salmon, I., Van Meirvenne, S., Thielemans, K. M., Goldman, M., & Flamand, V. (2003). Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo. Blood, 101(4), 1469-1476. doi:10.1182/blood-2002-07-2042
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>